# Capseicin (Capsaicinoid)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/capseicin
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-19
**Evidence Score:** 8 / 10
**Category:** Compound
**Also Known As:** 8-methylnonenamide, capsaicinoids, vanillyl amide, capsicin, trans-8-methylnonenamide, hot pepper extract, chili pepper alkaloid

## Overview

Capsaicin is a vanilloid compound from chili peppers that activates TRPV1 receptors to deplete substance P from nerve endings. This mechanism makes it particularly effective for treating neuropathic pain conditions.

## Health Benefits

• Reduces postherpetic neuralgia pain - 86% of patients maintained benefits over 2 years (strong evidence from RCT, n=143)
• Improves chemotherapy-induced peripheral neuropathy - significantly lower neuropathy grades vs control (moderate evidence from RCT, n=76)
• Enhances swallowing function in elderly with dysphagia - reduced aspiration risk and improved laryngeal closure time (moderate evidence from RCT, n=51)
• May reduce diabetic neuropathy pain - studied in 12-week double-blind trial (moderate evidence from RCT, n=40)
• Limited evidence for postoperative neuropathic pain - systematic review found only one RCT with non-significant results (very low certainty evidence)

## Mechanism of Action

Capsaicin binds to and activates TRPV1 (vanilloid receptor 1) channels on sensory neurons, causing initial excitation followed by desensitization. This process depletes substance P and CGRP from nerve terminals, reducing pain signal transmission. The receptor desensitization can last weeks to months, providing sustained analgesic effects.

## Clinical Summary

Strong evidence from a randomized controlled trial (n=143) shows 86% of postherpetic neuralgia patients maintained pain relief over 2 years with capsaicin treatment. Moderate evidence from an RCT (n=76) demonstrates significantly lower neuropathy grades in chemotherapy-induced peripheral neuropathy compared to control. Additional studies suggest benefits for swallowing function in elderly patients, though this evidence is more limited. Most clinical applications focus on topical formulations for localized pain management.

## Nutritional Profile

Capsaicin (8-methyl-N-vanillyl-6-nonenamide) is the principal capsaicinoid found in Capsicum species (chili peppers). It is not a significant source of macronutrients, vitamins, or minerals itself, as it is typically consumed or applied in microgram-to-milligram quantities. Key details: • Chemical formula: C18H27NO3; molecular weight: 305.41 g/mol. • Concentration in source foods: Fresh hot peppers contain approximately 0.1–1.0% capsaicinoids by dry weight; habanero peppers can reach up to 2–3% capsaicinoids. Capsaicin typically represents 60–70% of total capsaicinoids, with dihydrocapsaicin comprising ~20–25%, and minor capsaicinoids (nordihydrocapsaicin, homodihydrocapsaicin, homocapsaicin) making up the remainder. • Scoville Heat Units (SHU): Pure capsaicin rates ~16,000,000 SHU; dietary intake from hot peppers typically delivers 0.5–5 mg capsaicin per gram of dried chili. • Bioactive co-compounds in whole pepper matrix: Vitamin C (approximately 140–240 mg per 100 g fresh pepper), provitamin A carotenoids (β-carotene, β-cryptoxanthin; up to 10,000–20,000 µg per 100 g in red varieties), vitamin E (tocopherols; ~0.7–2.0 mg per 100 g), vitamin K (~14 µg per 100 g), potassium (~320 mg per 100 g), dietary fiber (~1.5–2.0 g per 100 g fresh), and flavonoids (luteolin, quercetin). • Bioavailability: Oral capsaicin is rapidly absorbed in the stomach and upper intestinal tract with approximately 50–90% bioavailability depending on formulation and food matrix. Peak plasma concentration occurs within 45–60 minutes of oral ingestion. It is extensively metabolized hepatically via CYP450 enzymes (primarily CYP3A4 and CYP1A2) and vanilloid pathways. Half-life in plasma is approximately 24–26 minutes. Lipophilic nature (logP ~3.04) facilitates transdermal absorption, which is exploited in topical patches (e.g., 8% capsaicin patch delivers ~179 mg per 280 cm² patch). Topical bioavailability is low systemically (<1% reaches circulation) but achieves high local tissue concentrations. • Mechanism of action target: Transient receptor potential vanilloid 1 (TRPV1) channel agonist; prolonged exposure causes defunctionalization of nociceptive nerve fibers via reversible depletion of substance P and calcitonin gene-related peptide (CGRP). • Typical dietary intake: Estimated average daily capsaicin consumption ranges from 0.5–1.0 mg/day in Western diets to 25–200 mg/day in high-consumption regions (Mexico, India, Thailand, Korea). • Therapeutic doses studied: Topical creams 0.025–0.1% applied 3–4 times daily; high-concentration patches 8% (179 mg capsaicin) single application for 30–60 minutes; oral supplements 2–6 mg/day in capsule form.

## Dosage & Preparation

Topical cream: 0.075% applied to affected areas (studied for neuropathic pain). High-concentration patch: 8% formulation for localized pain. Oral solution: 10 μM (10 mL three times daily before meals) for dysphagia. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Topical capsaicin commonly causes burning sensation, erythema, and skin irritation at application sites, typically diminishing with continued use. Systemic absorption is minimal with topical application, but oral capsaicin can cause gastric irritation and may interact with ACE inhibitors and anticoagulants. Contraindicated on broken or irritated skin and should be avoided during pregnancy and breastfeeding due to insufficient safety data. Patients should avoid contact with eyes and mucous membranes during application.

## Scientific Research

Clinical evidence includes a landmark double-blind trial (n=143) demonstrating significant pain reduction in postherpetic neuralgia with 0.075% capsaicin cream, and a randomized trial (n=51) showing improved swallowing function with 10 μM oral capsaicin solution. A systematic review (PROSPERO-registered) identified limited evidence for postoperative pain, while trials have shown promise for chemotherapy-induced neuropathy (n=76) and diabetic neuropathy (n=40).

## Historical & Cultural Context

The research dossier does not contain information on traditional medicine applications or historical use of capsaicin. Current evidence focuses exclusively on modern clinical applications.

## Synergistic Combinations

Not specified in research dossier

## Frequently Asked Questions

### Does capsaicin cream help with postherpetic neuralgia (shingles nerve pain)?

Yes, strong clinical evidence supports capsaicin for postherpetic neuralgia. A landmark double-blind RCT (n=143) found that 0.075% capsaicin cream provided significant pain reduction, with 86% of patients maintaining benefits over two years. The mechanism involves TRPV1 receptor activation that progressively depletes substance P and CGRP from nerve terminals, reducing pain signal transmission. Effects can persist for weeks to months after regular application due to sustained receptor desensitization. Consult a healthcare provider before beginning treatment.

### Can capsaicin help with chemotherapy-induced peripheral neuropathy?

Moderate evidence suggests capsaicin may benefit chemotherapy-induced peripheral neuropathy (CIPN). A randomized controlled trial (n=76) found patients using capsaicin experienced significantly lower neuropathy grades compared to controls. The analgesic effect stems from capsaicin depleting substance P and desensitizing TRPV1 receptors on peripheral sensory neurons — the same neurons damaged by chemotherapy agents. While results are promising, evidence is currently classified as moderate certainty, and oncology patients should discuss this option with their treatment team before use.

### What concentration of capsaicin patch is used for localized neuropathic pain?

An 8% high-concentration capsaicin patch is used for localized neuropathic pain conditions. This prescription-strength formulation delivers a concentrated dose directly to affected skin areas, producing prolonged TRPV1 receptor desensitization that can provide relief lasting weeks to months. This is significantly stronger than the 0.075% over-the-counter creams studied for broader neuropathic conditions. High-concentration patches are typically applied by healthcare professionals in clinical settings due to the intensity of the initial burning sensation and the need for proper application technique.

### Is capsaicin effective for diabetic neuropathy pain?

Capsaicin shows moderate promise for diabetic neuropathy pain. A 12-week double-blind randomized controlled trial (n=40) investigated its effects, with results supporting analgesic benefit. The mechanism is consistent with other neuropathic conditions: capsaicin activates TRPV1 receptors, causing desensitization that depletes substance P and reduces pain signaling in peripheral nerves — the nerves most affected in diabetic neuropathy. Evidence is currently classified as moderate certainty, meaning larger trials are still needed to confirm optimal dosing and long-term efficacy for this specific population.

### What are the side effects of using capsaicin cream?

The most common side effect of capsaicin cream is an initial burning, stinging, or warming sensation at the application site, which typically diminishes with repeated use as TRPV1 receptors become desensitized. Skin redness and irritation are also frequently reported. These effects reflect the mechanism of action — TRPV1 activation before desensitization occurs. Accidental contact with eyes or mucous membranes can cause intense irritation. Rare systemic side effects are unlikely with topical use at standard concentrations. Users should wash hands thoroughly after applying and avoid broken or irritated skin.

### Can capsaicin be taken orally, and what is the dose?

Yes, oral capsaicin has been studied for specific indications, particularly swallowing dysfunction (dysphagia) in elderly populations. A randomized controlled trial (n=51) used a 10 μM capsaicin oral solution administered as 10 mL taken three times daily before meals. This approach activated TRPV1 receptors in the oropharyngeal region, improving laryngeal closure time and reducing aspiration risk. Oral capsaicin use for systemic conditions requires medical supervision, and this specific dosing protocol should not be self-administered without guidance from a qualified healthcare provider.

### Does capsaicin help with postoperative neuropathic pain?

Current evidence for capsaicin in postoperative neuropathic pain is very limited and inconclusive. A PROSPERO-registered systematic review identified only a single eligible RCT examining this indication, and results were non-significant, earning a very low certainty evidence rating. This does not mean capsaicin is ineffective for postoperative pain, but rather that well-designed clinical trials are lacking. Given the established mechanisms — TRPV1 desensitization and substance P depletion — further research is warranted, but healthcare providers should not currently rely on capsaicin as a primary intervention for postoperative neuropathic pain.

### How does capsaicin's TRPV1 mechanism provide long-lasting pain relief?

Capsaicin binds to TRPV1 (vanilloid receptor 1) channels on sensory neurons, triggering an initial excitatory response followed by functional desensitization of those receptors. During repeated activation, nerve terminals progressively deplete stores of substance P and CGRP — key neuropeptides that transmit pain signals to the central nervous system. Once depleted, pain signal transmission is substantially reduced. Crucially, this receptor desensitization state can persist for weeks to months following a treatment course, explaining why clinical trials such as the postherpetic neuralgia RCT (n=143) observed sustained benefits over a two-year follow-up period.

### How does capsaicin work to relieve nerve pain?

Capsaicin binds to TRPV1 receptors on sensory neurons, triggering an initial burst of activity followed by prolonged desensitization. This process depletes substance P and CGRP — key neurotransmitters involved in pain signal transmission — from nerve terminals. The result is reduced pain signaling that can persist for weeks to months after application. This makes capsaicin particularly effective for neuropathic pain conditions where conventional analgesics often fall short, as it targets the peripheral nerve fibers directly rather than masking central pain perception.

### Can capsaicin help with swallowing difficulties in elderly people?

Yes, there is moderate clinical evidence supporting capsaicin for dysphagia in older adults. A randomized controlled trial of 51 elderly patients found that an oral capsaicin solution (10 μM, taken three times daily before meals) significantly reduced aspiration risk and improved laryngeal closure time. The mechanism involves TRPV1 stimulation in the oropharynx, which may enhance the swallowing reflex. This application is distinct from topical pain uses and should be discussed with a healthcare provider before trying.

### What is the correct dosage of capsaicin cream for neuropathic pain?

The most clinically studied topical formulation for neuropathic pain is a 0.075% capsaicin cream applied to the affected area. This concentration was used in a landmark double-blind trial of 143 patients with postherpetic neuralgia demonstrating significant pain reduction. A higher-concentration 8% patch is also available for localized neuropathic pain but is typically administered in a clinical setting. For dysphagia, a 10 μM oral solution taken three times daily before meals has been studied. Always consult a healthcare provider to determine the appropriate formulation and dosage.

### How long does it take for capsaicin cream to work?

Capsaicin typically requires consistent application over several weeks before meaningful pain relief is achieved. The initial phase often involves a temporary burning or stinging sensation as TRPV1 receptors are activated and substance P is depleted. As desensitization progresses, pain levels generally decrease. Clinical trials studying the 0.075% cream for postherpetic neuralgia and diabetic neuropathy typically ran for 8 to 12 weeks, with benefits accumulating over that period. High-concentration 8% patches may provide faster onset but are administered under clinical supervision.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*